Khiron Life Sciences Appoints Franziska Katterbach as President for Europe
Medical cannabis company Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), announced the appointment of Franziska Katterbach as President of Khiron Europe, replacing Tejinder Virk, who has resigned from the company. Hired in October 2019 as Managing Director and Chief Legal Counsel of Khiron Europe, Katterbach’s promotion toRead More →